Literature DB >> 10397163

Signaling complex formation of CD44 with src-related kinases.

Z Rozsnyay1.   

Abstract

The complex formation of murine CD44 with the src-like protein tyrosine kinases, lck and lyn, was investigated. In accordance with previous observations, stable CD44-lck and CD44-lyn complexes were detected in nonstimulated lymphoid T- and B-cells, respectively. In addition, a direct modulation of lck and lyn by CD44 was observed as revealed by the CD44-dependent translocation of these enzymes to the Triton X-100 resistant cell fraction. To clarify which receptor domain is responsible for the association, peptide binding assays were performed. Interestingly, the synthetic peptide pCD44 (ILAVCIAVNSRRR), which corresponds to the plasma membrane-cytoplasmic interface region of murine CD44, exhibited a high capacity to bind lck and lyn. A single amino acid modification in the position of the cysteine residue completely abolished this interaction, while the truncation of the three tandem arginines significantly decreased it. Remarkably, similar sequences were found in a number of other molecules including subunits of receptors recognizing antigens, immunoglobulins, extracellular matrix components, accessory molecules, cytokines and also in certain viral gene products. Synthetic peptides corresponding to the homologous regions found in CD28 and FcepsilonRIbeta were also studied and comparable lck-lyn-binding potentials were detected. These data suggest a novel interaction between src-family kinases and CD44, CD28, FcepsilonRIbeta, and provide a simple model for the association of src-like kinases with transmembrane proteins.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10397163     DOI: 10.1016/s0165-2478(99)00037-1

Source DB:  PubMed          Journal:  Immunol Lett        ISSN: 0165-2478            Impact factor:   3.685


  10 in total

Review 1.  Hyaluronan in immune dysregulation and autoimmune diseases.

Authors:  Nadine Nagy; Hedwich F Kuipers; Payton L Marshall; Esther Wang; Gernot Kaber; Paul L Bollyky
Journal:  Matrix Biol       Date:  2018-04-04       Impact factor: 11.583

2.  Multifaceted regulation of T cells by CD44.

Authors:  Bas Jg Baaten; Cheng-Rui Li; Linda M Bradley
Journal:  Commun Integr Biol       Date:  2010-11-01

Review 3.  Balancing natural killer cell activation through paired receptors.

Authors:  Ludovic Martinet; Mark J Smyth
Journal:  Nat Rev Immunol       Date:  2015-03-06       Impact factor: 53.106

4.  Distinct effects of saracatinib on memory CD8+ T cell differentiation.

Authors:  Shinji Takai; Helen Sabzevari; Benedetto Farsaci; Jeffrey Schlom; John W Greiner
Journal:  J Immunol       Date:  2012-03-26       Impact factor: 5.422

Review 5.  CD44 in cancer progression: adhesion, migration and growth regulation.

Authors:  R Marhaba; M Zöller
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

6.  Macrophage migration inhibitory factor down-regulates the RANKL-RANK signaling pathway by activating Lyn tyrosine kinase in mouse models.

Authors:  Se Hwan Mun; Dongmyung Oh; Sun-Kyeong Lee
Journal:  Arthritis Rheumatol       Date:  2014-09       Impact factor: 10.995

7.  CD44 regulates survival and memory development in Th1 cells.

Authors:  Bas J G Baaten; Cheng-Rui Li; Mia F Deiro; Melissa M Lin; Phyllis J Linton; Linda M Bradley
Journal:  Immunity       Date:  2010-01-14       Impact factor: 31.745

8.  Regulation of Antigen-Experienced T Cells: Lessons from the Quintessential Memory Marker CD44.

Authors:  Bas J G Baaten; Roberto Tinoco; Alex T Chen; Linda M Bradley
Journal:  Front Immunol       Date:  2012-02-27       Impact factor: 7.561

Review 9.  Coming of Age: CD96 Emerges as Modulator of Immune Responses.

Authors:  Hristo Georgiev; Inga Ravens; Georgia Papadogianni; Günter Bernhardt
Journal:  Front Immunol       Date:  2018-05-17       Impact factor: 7.561

10.  RIP2 Is a Critical Regulator for NLRs Signaling and MHC Antigen Presentation but Not for MAPK and PI3K/Akt Pathways.

Authors:  Xiao Man Wu; Wen Qin Chen; Yi Wei Hu; Lu Cao; Pin Nie; Ming Xian Chang
Journal:  Front Immunol       Date:  2018-04-10       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.